Drew Thomas
Cardiovascular Disease · Overland Park, KSNPI 1235626334
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,763 of the $3,226 with a category attached, or 85.6%. It is spread thinly across 24 manufacturers, the largest accounting for just 15.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,061, 7.0 times the $151 reported in 2021.
Across 90 payments — averaging $35.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$505
- Medtronic$461
- Boston Scientific$284
- Johnson & Johnson$234
- Philips North America LLC$227
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$211
- plus $1K from 18 others
What the payments were for
- Food & beverage$2,76386%
- Education$46314%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 10 | $505 |
| Medtronic | 3 | $461 |
| Boston Scientific | 4 | $284 |
| Johnson & Johnson | 17 | $234 |
| Philips North America LLC | 3 | $227 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $211 |
| AstraZeneca | 5 | $199 |
| Boehringer Ingelheim | 11 | $168 |
| Abiomed | 2 | $134 |
| Novartis | 8 | $130 |
| Janssen Scientific Affairs, LLC | 1 | $125 |
| Pfizer | 4 | $117 |
| E.r. Squibb & Sons, L.L.C. | 1 | $109 |
| Alnylam Pharmaceuticals Inc. | 1 | $73 |
| Bayer | 3 | $55 |
| Amarin Pharma, Inc. | 2 | $33 |
| Angiodynamics, Inc. | 1 | $33 |
| Penumbra, Inc. | 1 | $25 |
| Cardiva Medical, Inc. | 1 | $24 |
| Siemens Medical Solutions USA, Inc. | 1 | $18 |
| Teleflex LLC | 1 | $16 |
| Actelion Pharmaceuticals US, Inc. | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Amgen | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENSITE$242
- RESOLUTE ONYX$221
- ONYX FRONTIER$157
- WATCHMAN Access System$149
- (9520) IGT Devices Undivided$144
- XARELTO$125
- Impella$119
- WAINUA$111
- CAMZYOS$109
How this compares
$3,226 in reported general payments places this provider in the 55th percentile of 175 cardiovascular disease providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 14 | $100 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Overland Park
- Vasvi SinghOverland Park$405K
- Rachel SoslandOverland Park$33K
- Ahmed ElballatOverland Park$22K
- Paul NagerOverland Park$10K
- Ronnie SmallingOverland Park$9K
- van JonesOverland Park$7K
- Alan SchneiderOverland Park$6K
- Theodore PopeOverland Park$5K
- Stephen BloomOverland Park$5K
- James MarcumOverland Park$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.